| Literature DB >> 30116605 |
Yanqun Wang1, Jing Sun1, Airu Zhu1, Jingxian Zhao1, Jincun Zhao1,2.
Abstract
Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel betacoronavirus (MERS coronavirus, MERS-CoV). Since its first emergence in 2012, multiple transmission events of MERS-CoV (dromedary to human and human to human) have been reported, indicating that MERS-CoV has the potential to cause widespread outbreak. However, the epidemiology of MERS as well as immune responses against the virus in animal models and patients are still not well understood, hindering the vaccine and therapeutic developments. In this review, we summarize recent genetic and epidemic findings of MERS-CoV and the progress in animal model development, immune response studies in both animals and humans. At last, we discussed the breakthrough on vaccine and therapeutic development which are important against potential future MERS outbreak.Entities:
Keywords: Middle East respiratory syndrome coronavirus (MERS-CoV); animal model; antiviral therapy; epidemiology; immune response
Year: 2018 PMID: 30116605 PMCID: PMC6072923 DOI: 10.21037/jtd.2018.03.80
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895